David Turkaly
Stock Analyst at Citizens JMP
(0.27)
# 4,543
Out of 5,044 analysts
440
Total ratings
39.5%
Success rate
-3.7%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENOV Enovis | Reiterated: Buy | $55 → $47 | $17.69 | +165.69% | 5 | Sep 2, 2026 | |
| SYK Stryker | Reiterated: Buy | $440 → $400 | $277.33 | +44.23% | 22 | Aug 3, 2026 | |
| AXGN Axogen | Reiterated: Buy | $50 → $55 | $36.13 | +52.23% | 31 | Jul 30, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Buy | $85 → $115 | $100.15 | +14.83% | 21 | May 8, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $7 → $6 | $4.67 | +28.48% | 3 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Buy | $125 → $105 | $89.14 | +17.79% | 29 | Apr 29, 2026 | |
| TELA TELA Bio | Reiterated: Buy | $5 → $3 | $1.11 | +170.27% | 23 | Mar 27, 2026 | |
| APYX Apyx Medical | Upgraded: Buy | $8 | $2.59 | +208.88% | 34 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Reiterated: Buy | $35 → $25 | $21.65 | n/a | 37 | Oct 10, 2025 | |
| GMED Globus Medical | Reiterated: Hold | n/a | $74.65 | n/a | 24 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $13.44 | n/a | 31 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.13 | n/a | 23 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $118.69 | n/a | 33 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $280 | $214.40 | n/a | 40 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $19.37 | n/a | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $125.12 | n/a | 24 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.17 | n/a | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.66 | n/a | 10 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.65 | n/a | 2 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $64.85 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $7.36 | n/a | 1 | Jun 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.90 | n/a | 1 | Jun 25, 2009 |
Enovis
Sep 2, 2026
Reiterated: Buy
Price Target: $55 → $47
Current: $17.69
Upside: +165.69%
Stryker
Aug 3, 2026
Reiterated: Buy
Price Target: $440 → $400
Current: $277.33
Upside: +44.23%
Axogen
Jul 30, 2026
Reiterated: Buy
Price Target: $50 → $55
Current: $36.13
Upside: +52.23%
Lantheus Holdings
May 8, 2026
Reiterated: Buy
Price Target: $85 → $115
Current: $100.15
Upside: +14.83%
MiMedx Group
Apr 30, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $4.67
Upside: +28.48%
Zimmer Biomet Holdings
Apr 29, 2026
Reiterated: Buy
Price Target: $125 → $105
Current: $89.14
Upside: +17.79%
TELA Bio
Mar 27, 2026
Reiterated: Buy
Price Target: $5 → $3
Current: $1.11
Upside: +170.27%
Apyx Medical
Nov 12, 2025
Upgraded: Buy
Price Target: $8
Current: $2.59
Upside: +208.88%
OrthoPediatrics
Oct 10, 2025
Reiterated: Buy
Price Target: $35 → $25
Current: $21.65
Upside: n/a
Globus Medical
Aug 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $74.65
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $25
Current: $13.44
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: $7
Current: $2.13
Upside: n/a
May 20, 2025
Reiterated: Buy
Price Target: $100
Current: $118.69
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $265 → $280
Current: $214.40
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $32
Current: $19.37
Upside: n/a
Apr 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $125.12
Upside: n/a
Mar 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.17
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $9.66
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $7.65
Upside: n/a
Jun 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $64.85
Upside: n/a
Jun 3, 2016
Reiterated: Buy
Price Target: $17
Current: $7.36
Upside: n/a
Jun 25, 2009
Downgraded: Hold
Price Target: n/a
Current: $3.90
Upside: n/a